Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

Suzhou Suncadia Biopharmaceuticals Co: Clinical Trials & FDA Approval Profile

Suzhou Suncadia Biopharmaceuticals Co (Global / Institutional) sponsors 75 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 54 active protocols (37 recruiting now), 3 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)8.0%
Median Closed Enrollment vs National (145 pts)121 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Suzhou Suncadia Biopharmaceuticals Co
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)75
Active Pipeline (Recruiting Now)54 (37)
Completed vs Stopped Early3 / 6 (8.0%)
Median Closed Actual Enrollment121 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Suzhou Suncadia Biopharmaceuticals Co
Hospital Research SiteLocationShared Protocols
Sun Yat-sen University Cancer CenterGuangzhou, Guangdong8
Zhongshan Hospital Fudan UniversityShanghai7
Beijing Cancer HospitalBeijing, Beijing Municipality7

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Suzhou Suncadia Biopharmaceuticals Co
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05149807Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric CancerPhase II/IIITERMINATED

Explore interactive annual charts and M&A subsidiary rollups in the Suzhou Suncadia Biopharmaceuticals Co Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI